Tag:
Perampanel
Latest Headlines
Latest Headlines
FDA refuses to file Eisai app for new epilepsy drug
The FDA has taken a red pen to Eisai's application for approval of perampanel for epilepsy patients, handing the Japan-based drugmaker a refusal to file letter for the NDA submitted in May. It's
Does Eisai's epilepsy drug work? Yes and no
Some seemingly contradictory headlines are coming out of the American Academy of Neurology meeting in Honolulu, where Bloomberg reports that Eisai's epilepsy drug perampanel did not significantly
Eisai drug flunks Parkinson's trial
Eisai's has halted development of Perampanel (E2007) for Parkinson's after the drug failed a late-stage trial. Compared with placebo, E2007 didn't show a significant difference in the primary
